Phio Pharmaceuticals Presenting Data on Its INSTAYL Compound PH-894 at ASGCT's 2024 Advancing Gene and Cell Therapies for Cancer Conference
Phio Pharmaceuticals(PHIO) Newsfile·2024-10-16 12:00● ● . | --- | --- | |----------------------------------------------|-------| | | | | INSTAYL Compound PH-894 at ASGCT's 2024 | | | Advancing Gene and Cell Therapies for Cancer | | October 16, 2024 8:00 AM EDT | Source: Phio Pharmaceuticals Corp. PH-894: Potent and Specific Silencing of BRD4 in NK Cells Marlborough, Massachusetts--(Newsfile Corp. - October 16, 2024) - Phio Pharmaceuticals Corp. (NASDAQ: PHIO) is a clinical-stage biotechnology company creating new pathways towards a cancer-free future by usin ...